Hemostemix Inc’s. accomplishments in the medication
Post# of 23
(Total Views: 221)
Posted On: 05/25/2022 12:05:24 PM
Hemostemix Inc. (OTCQB: HMTXF ) won the World Economic Forum’s technology pioneer award. The company has been running a clinical-stage trial for over 4.5 years and is toward the finish of its 2nd stage clinical trial of ACP-01, with positive outcomes.
(0)
(0)Hemostemix Inc (HMTXF) Stock Research Links
Scroll down for more posts ▼